Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      IMAX Corporation Reports Fourth Quarter and Full-Year 2019 Results

      IMAX Logo. (PRNewsFoto/IMAX Corporation)

      News provided by

      IMAX Corporation

      Feb 19, 2020, 16:05 ET

      Share this article

      Share this article


      NEW YORK, Feb. 19, 2020 /PRNewswire/ -- IMAX Corporation (NYSE:IMAX) today reported full-year 2019 revenues of $395.7 million, gross profit of $214.2 million, net income of $58.6 million, or $0.95 per diluted share, and net income attributable to common shareholders of $46.9 million, or $0.76 per diluted share. Adjusted net income attributable to common shareholders for the year ended December 31, 2019 was $64.8 million, or $1.05 per diluted share. Adjusted EBITDA attributable to common shareholders was $149.3 million.

      HIGHLIGHTS

      • Company achieved record full-year 2019 box office of $1.1 billion, up 7% over the prior year
      • Full-year 2019 revenue increased 6% versus 2018 to $396 million, a new record
      • Full-year 2019 net income attributable to common shareholders increased 105% versus 2018 to $47 million and full-year 2019 net income increased 74% to $59 million; Adjusted net income attributable to common shareholders increased 12% year-over-year to $65 million
      • Full-year 2019 earnings per share attributable to common shareholders increased 111% to $0.76; Adjusted net earnings per share attributable to common shareholders increased 15% to $1.05
      • Company's total commercial multiplex network grew to 1,529 theatres, 73% of which are in international markets


      Three Months Ended



      12 Months Ended



      December 31,



      December 31,

      In millions, except per share data


      2019


      2018


      YoY %



      2019


      2018


      YoY %







      Change







      Change

      Total Revenue

      $

      124.3

      $

      109.0


      14%


      $

      395.7

      $

      374.4


      6%















      Gross Margin


      62.4


      54.6


      14%



      214.2


      207.9


      3%

         Gross Margin (%)


      50.2%


      50.1%





      54.1%


      55.5%

















      Net Income

      $

      21.4

      $

      3.8


      461%


      $

      58.6

      $

      33.6


      74%

      Net Income(1)


      18.2


      1.7


      973%



      46.9


      22.8


      105%

      Adjusted Net Income (1)


      21.5


      16.4


      31%



      64.8


      57.8


      12%

      Diluted Net Income Per Share(1) 

      $

      0.29

      $

      0.03


      867%


      $

      0.76

      $

      0.36


      111%

      Adj. Net Income Per Share(1)

      $

      0.35

      $

      0.26


      35%


      $

      1.05

      $

      0.91


      15%















      Adjusted EBITDA

      $

      47.0

      $

      36.4


      29%


      $

      149.3

      $

      133.2


      12%

         Adj. EBITDA Margin (%)


      41.7%


      37.3%





      41.7%


      39.6%

















      (1) Attributable to common shareholders














      Note: For the definition and reconciliations of reported results to non-GAAP financial results, please refer to the discussion of non-GAAP financial measures at the end of this earnings release.

      The Company also reported fourth quarter 2019 revenues of $124.3 million, gross profit of $62.4 million, net income of $21.4 million, or $0.35 per diluted share, and net income attributable to common shareholders of $18.2 million, or $0.29 per diluted share. Adjusted net income attributable to common shareholders for the fourth quarter was $21.5 million, or $0.35 per diluted share. Adjusted EBITDA attributable to common shareholders was $47.0 million. For reconciliations of reported results to non-GAAP financial results, and for the definition and reconciliation of Adjusted EBITDA, please see the end of this press release.

      "IMAX is among the world's premiere entertainment experiences, and our record 2019 financial results reflect sharp focus, strong execution, and disciplined cost management as we continue to grow our global footprint, diversify our content portfolio, and enhance our pioneering end-to-end technology," said IMAX CEO Richard L. Gelfond.

      "Across 2019, our business demonstrated significant strength by setting a number of new records for the Company including annual revenue as well as global, international, and local language box office — underscoring the increasing geographic diversification of our business."

      "In a world of nearly infinite entertainment choices, audiences continue to choose IMAX. Immersive entertainment experiences continue to connect fans and drive culture around the globe. We are committed to building on strong demand for The IMAX Experience® to strengthen our unique position in the entertainment ecosystem and deliver value for our shareholders."

      "In terms of the health crisis in China, where movie theatres nationwide remain closed, we are continuing to monitor the situation closely and needless to say the safety of our team and audiences is our top priority," said Mr. Gelfond. "We look forward to circumstances improving and IMAX continuing to satisfy China's strong demand for premium quality content and entertainment experiences."

      Fourth Quarter and Full-Year Segment Results






      Network Business


      Theatre Business




      Revenue


      Gross

      Margin

      Gross

      Margin %


      Revenue


      Gross

      Margin

      Gross

      Margin %














      4Q19

      $

      43.0

      $

      24.4

      56.8%

      $

      77.6

      $

      39.7

      51.2%


      4Q18

      $

      41.7


      24.7

      59.2%


      61.9


      29.1

      47.1%


      % change


      3.3%


      (0.9%)



      25.3%


      36.4%















      YTD 4Q19

      $

      196.8

      $

      126.7

      64.4%

      $

      180.5

      $

      86.8

      48.1%


      YTD 4Q18

      $

      184.2


      121.6

      66.0%


      168.4


      85.8

      50.9%


      % change


      6.9%


      4.1%



      7.2%


      1.2%














      Network Business

      • Network business revenues increased 6.9% to $196.8 million in 2019, compared to $184.2 million in the prior-year period. The strong overall increase in network business revenues was primarily driven by a $76.4 million, or 7.4%, increase in IMAX global box office to $1.1 billion.
      • Total gross margin for the network business was 64.4% in the most recent quarter, compared to 66.0% in the prior-year period. The year-over-year decrease in total gross margin was primarily driven by increased contractual marketing expense.

      Theatre Business

      • Theatre business segment revenues increased 7.2% to $180.5 million in 2019, compared with $168.4 million in the prior-year period.
      • Total gross margin for the theatre business was 48.1% compared to 50.9% in the prior-year period. The year-over-year decline in total gross margin was primarily driven by the geographic and system mix of installations in the first quarter of 2018. The theatre business gross margin increased steadily throughout 2019, landing at 51.2% for the entire segment in the fourth quarter of 2019, and 53.0% specifically for sales and sales type lease theatres.

      Cash Balances and Outstanding Debt

      Total cash and cash equivalents as of December 31, 2019 was $109.5 million. Total bank indebtedness was $18.2 million as of December 31, 2019 and represented a decrease compared to $37.8 million as of December 31, 2018. As of December 31, 2019, $280.0 million was available under the Company's $300.0 million credit facility due June 28, 2023.

      Share Count and Capital Return

      • The weighted average diluted shares outstanding at the end of the fourth quarter of 2019 declined 2.7% to 61.5 million, compared to 63.2 million in fourth quarter 2018, due primarily to share repurchase activity. During 2019 a total of 134 thousand shares were repurchased at an average price of $19.76 for a total value of approximately $2.7 million. A total of $125.9 million remains available under the Company's outstanding share repurchase authorization, which expires in June 2020.
      • During 2019, IMAX China repurchased a total of 8.05 million shares at an average price of $2.38 for a total value of approximately $19.2 million.

      Supplemental Materials

      For more information about the Company's results, please refer to the IMAX Investor Relations website located at investors.imax.com.

      Investor Relations Website and Social Media

      On a weekly basis, the Company posts quarter-to-date box office results on the IMAX Investor Relations website located at www.imax.com/content/investor-relations. The Company expects to provide such updates on Friday of each week, although the Company may change this timing without notice. Results will be displayed with a one-week lag.

      The information posted on the Company's website may be deemed material to investors. Accordingly, investors, media and others interested in the Company should monitor the Company's website in addition to the Company's press releases, SEC filings and public conference calls and webcasts.

      Conference Call

      The Company will host a conference call today at 4:30PM ET to discuss its fourth quarter and full year 2019 financial results. This call is being webcast by Nasdaq and can be accessed at www.imax.com/content/investor-relations. To access the call via telephone, interested parties in the US and Canada should dial (888) 204-4368 approximately 5 to 10 minutes before the call begins. Other international callers should dial (647) 794-4605. The conference ID for the call is 9833755. A replay of the call will be available via webcast at www.imax.com/content/investor-relations or via telephone by dialing (888) 203-1112 (US and Canada), or (647) 436-0148 (international). The Conference ID for the telephone replay is 9833755.

      About IMAX Corporation

      IMAX, an innovator in entertainment technology, combines proprietary software, architecture and equipment to create experiences that take you beyond the edge of your seat to a world you've never imagined. Top filmmakers and studios are utilizing IMAX theatres to connect with audiences in extraordinary ways, and, as such, IMAX's network is among the most important and successful theatrical distribution platforms for major event films around the globe.

      IMAX is headquartered in New York, Toronto, and Los Angeles, with additional offices in London, Dublin, Tokyo, and Shanghai. As of December 31, 2019, there were 1,624 IMAX theatre systems (1,529 commercial multiplexes, 14 commercial destinations, 81 institutional) operating in 81 countries and territories. Shares of IMAX China, a subsidiary of IMAX Corp., trade on the Hong Kong Stock Exchange under the stock code "HK.1970."

      IMAX®, IMAX® 3D, IMAX DMR®, Experience It In IMAX®, An IMAX 3D Experience®, The IMAX Experience®, IMAX Is Believing® and IMAX nXos® are trademarks of IMAX Corporation. More information about the Company can be found at www.imax.com. You may also connect with IMAX on Instagram (https://www.instagram.com/imax), Facebook (www.facebook.com/imax), Twitter (www.twitter.com/imax) and YouTube (www.youtube.com/imaxmovies).

      For additional information please contact:

      Investors:

      IMAX Corporation, New York

      Heather Anthony

      212-821-0121

      [email protected]

      Media:

      IMAX Corporation, New York

      Mark Jafar

      212-821-0155

      [email protected]

      Forward-Looking Statements

      This earnings release contains forward looking statements that are based on IMAX management's assumptions and existing information and involve certain risks and uncertainties which could cause actual results to differ materially from future results expressed or implied by such forward looking statements. Important factors that could affect these statements include, but are not limited to, references to future capital expenditures (including the amount and nature thereof), business and technology strategies and measures to implement strategies, competitive strengths, goals, expansion and growth of business, operations and technology, plans and references to the future success of IMAX Corporation together with its consolidated subsidiaries (the "Company") and expectations regarding the Company's future operating, financial and technological results. These forward-looking statements are based on certain assumptions and analyses made by the Company in light of its experience and its perception of historical trends, current conditions and expected future developments, as well as other factors it believes are appropriate in the circumstances. However, whether actual results and developments will conform with the expectations and predictions of the Company is subject to a number of risks and uncertainties, including, but not limited to, risks associated with investments and operations in foreign jurisdictions and any future international expansion, including those related to economic, political and regulatory policies of local governments and laws and policies of the United States and Canada; risks related to the Company's growth and operations in China, including the adverse impact of the coronavirus outbreak in China; the performance of IMAX DMR® films; the signing of theater system agreements; conditions, changes and developments in the commercial exhibition industry; risks related to currency fluctuations; the potential impact of increased competition in the markets within which the Company operates; competitive actions by other companies; the failure to respond to change and advancements in digital technology; risks relating to recent consolidation among commercial exhibitors and studios; risks related to new business initiatives; conditions in the in-home and out-of-home entertainment industries; the opportunities (or lack thereof) that may be presented to and pursued by the Company; risks related to cyber-security and data privacy; risks related to the Company's inability to protect the Company's intellectual property; general economic, market or business conditions; the failure to convert theater system backlog into revenue; changes in laws or regulations; the failure to fully realize the projected cost savings and benefits from any of the Company's restructuring initiatives; and other factors, many of which are beyond the control of the Company. These factors, other risks and uncertainties and financial details are discussed in IMAX's most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. The Company undertakes no obligation to update publicly or otherwise revise any forward-looking statements, whether as a result of new information, future events or otherwise.

      Primary Reporting Groups

      The Company has four primary reporting groups identified by nature of product sold or service provided: (1) Network Business, representing variable revenue generated by box-office results and which includes the reportable segments of IMAX DMR and contingent rent from the JRSAs and IMAX systems segments; (2) Theater Business, representing revenue generated by the sale and installation of theater systems and maintenance services, primarily related to the IMAX Systems and Theater System Maintenance reportable segments, and also includes fixed hybrid revenues and upfront installation costs from the JRSA segment; (3) New Business, which includes home entertainment, and other new business initiatives that are in the development, start-up and/or wind-up phases, and (4) Other; which includes the film post-production and distribution segments and certain IMAX theaters that the Company owns and operates, camera rentals and other miscellaneous items.

      Non-GAAP Financial Measures

      In this release, the Company presents adjusted net income, adjusted net income per diluted share, adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share, EBITDA, Adjusted EBITDA per Credit Facility, Adjusted EBITDA margin, free cash flow and return on invested capital as supplemental measures of performance of the Company, which are not recognized under U.S. GAAP. The Company presents adjusted net income and adjusted net income per diluted share because it believes that they are important supplemental measures of its comparable controllable operating performance and it wants to ensure that its investors fully understand the impact of its stock-based compensation (net of any related tax impact) and non-recurring charges on net income. In addition, the Company presents adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share because it believes that they are important supplemental measures of its comparable financial results and could potentially distort the analysis of trends in business performance and it wants to ensure that its investors fully understand the impact of net income attributable to non-controlling interests and its stock-based compensation (net of any related tax impact) and non-recurring charges in determining net income attributable to common shareholders. Management uses these measures to review operating performance on a comparable basis from period to period. However, these non-GAAP measures may not be comparable to similarly titled amounts reported by other companies. Adjusted net income, adjusted net income per diluted share, adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share should be considered in addition to, and not as a substitute for, net income and net income attributable to common shareholders and other measures of financial performance reported in accordance with U.S. GAAP.

      The Company is required to maintain a minimum level of "EBITDA", as such term is defined in the Company's credit agreement (and which is referred to herein as "Adjusted EBITDA per Credit Facility", as the credit agreement includes additional adjustments beyond interest, taxes, depreciation and amortization). EBITDA and Adjusted EBITDA per Credit Facility (each as defined below) should not be construed as substitutes for net income or as better measures of liquidity as determined in accordance with U.S. GAAP. The Company believes that EBITDA, Adjusted EBITDA per Credit Facility and Adjusted EBITDA margin are relevant and useful information widely used by analysts, investors and other interested parties in the Company's industry. Accordingly, the Company is disclosing this information to permit a more comprehensive analysis of its operating performance and to provide additional information with respect to the Company's ability to comply with its credit agreement requirements.

      Free cash flow is defined as cash provided by operating activities minus cash used in investing activities (from the condensed consolidated statements of cash flows). Cash provided by operating activities consist of net income, plus depreciation and amortization, plus the change in deferred income taxes, plus other non-cash items, plus changes in working capital, less investment in film assets, plus other changes in operating assets and liabilities. Cash used in investing activities includes capital expenditures, acquisitions and other cash used in investing activities. Management views free cash flow, a non-GAAP measure, as a measure of the Company's after-tax cash flow available to reduce debt, add to cash balances, and fund other financing activities. Free cash flow does not represent residual cash flow available for discretionary expenditures. A reconciliation of cash provided by operating activities to free cash flow is presented below. 

      Signings and Installations












      12 Months Ended December 31,



      Theater System Signings:

      2019


      2018



      Full new sales and sales-type lease arrangements

      49


      57



      New traditional joint revenue sharing arrangements

      7


      55



      New hybrid joint revenue sharing lease arrangements

      48


      10



      Total new theaters

      104


      122



      Upgrades of IMAX theater systems

      39


      112

      (1)


          Total theater signings

      143


      234
















      12 Months Ended December 31,



      Theater System Installations:

      2019


      2018



      Full new sales and sales-type lease arrangements

      55

      (2)

      63



      New traditional joint revenue sharing arrangements

      54


      72



      New hybrid joint revenue sharing lease arrangements

      20


      14



      Total new theaters

      129


      149



      Upgrades of IMAX theater systems

      57


      23



         Total theater installations

      186


      172










      12 Months Ended December 31,






      Theater Sales Backlog:

      2019


      2018



      Sales and sales-type lease arrangements

      178


      177



      Joint revenue sharing arrangements






      Hybrid lease arrangements

      140


      118



      Traditional arrangements

      213

      (3)

      269

      (5)


      Total theater backlog

      531

      (4)

      564

      (6)









      12 Months Ended December 31,






      Theater Network:

      2019


      2018



      Commercial Multiplex Theaters:






      Sales and sales-type lease arrangements

      659


      611



      Traditional joint revenue sharing arrangements

      731


      674



      Hybrid joint revenue sharing lease arrangements

      139


      124



      Total Commercial Multiplex Theaters

      1,529


      1,409









      Commercial Destination Theaters

      14


      14



      Institutional Theaters

      81


      82



         Total theater network

      1,624


      1,505








      (1)     Includes 105 theater systems related to existing AMC, Regal and Pathé theaters to be upgraded to IMAX with Laser projection systems on new lease terms ranging from 10 to 12 years. 

      (2)     Includes one IMAX digital theater system that was relocated from a previous location. This installation is incremental to the IMAX theater network but full revenue for the digital theater system was not received.

      (3)    Includes 47 theater systems where the customer has the option to convert from a joint revenue sharing arrangement to a sales arrangement.

      (4)     Includes 153 new laser projection system configurations (144 of which are IMAX with Laser projection system configurations and 9 of which are GT Lasers) and 97 upgrades of existing locations to laser projection system configurations (92 of which are for the IMAX with Laser projection system configurations and 5 of which are GT Lasers).

      (5)    Includes 46 theater systems where the customer has the option to convert from a joint revenue sharing arrangement to a sales arrangement.

      (6)    Includes 83 new laser projection system configurations (73 of which are IMAX with Laser projection system configurations and 10 of which are GT Lasers) and 100 upgrades of existing locations to laser projection system configurations (98 of which are for the IMAX with Laser projection system configurations and 2 of which are GT Lasers).

      IMAX CORPORATION

      CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS


      In accordance with United States Generally Accepted Accounting Principles

      (In thousands of U.S. dollars, except per share amounts)



















      Three Months Ended


      12 Months Ended




      December 31,


      December 31,




      2019


      2018


      2019


      2018

      Revenues













      Equipment and product sales


      $

      61,616


      $

      46,409


      $

      118,245


      $

      106,591

      Services 



      43,570



      42,769



      188,547



      181,740

      Rentals



      16,286



      16,667



      77,961



      74,472

      Finance income



      2,807



      3,119



      10,911



      11,598





      124,279



      108,964



      395,664



      374,401

      Costs and expenses applicable to revenues













      Equipment and product sales 



      30,513



      25,233



      63,627



      54,853

      Services



      21,970



      21,428



      88,175



      84,236

      Rentals 



      9,437



      7,661



      29,690



      27,383





      61,920



      54,322



      181,492



      166,472

      Gross margin



      62,359



      54,642



      214,172



      207,929

      Selling, general and administrative expenses



      34,189



      30,380



      123,456



      117,477

      Research and development



      1,486



      2,186



      5,203



      13,728

      Amortization of intangibles



      1,391



      1,249



      4,955



      4,145

      Receivable provisions, net of recoveries



      473



      1,463



      2,430



      3,130

      Legal arbitration award



      -



      4,237



      -



      11,737

      Executive transition cost



      -



      2,994



      -



      2,994

      Exit costs, restructuring charges and associated impairments



      -



      8,384



      850



      9,542

      Income from operations



      24,820



      3,749



      77,278



      45,176

      Change in fair value of equity securities



      2,026



      -



      (517)



      -

      Retirement benefits non-service expense



      (257)



      (125)



      (737)



      (499)

      Interest income



      473



      723



      2,105



      1,844

      Interest expense



      (987)



      (613)



      (2,793)



      (2,916)

      Income before income taxes



      26,075



      3,734



      75,336



      43,605

      Provision for income taxes



      (4,782)



      22



      (16,768)



      (9,518)

      Income (loss) from equity-accounted investments, net of tax


      59



      15



      3



      (492)

      Net income 



      21,352



      3,771



      58,571



      33,595

      Less: net income attributable to non-controlling interests



      (3,181)



      (2,077)



      (11,705)



      (10,751)

      Net income attributable to common shareholders


      $

      18,171


      $

      1,694


      $

      46,866


      $

      22,844















      Net income per share attributable to common shareholders -
            basic and diluted:










      Net income per share — basic and diluted


      $

      0.29


      $

      0.03


      $

      0.76


      $

      0.36















      Weighted average number of shares outstanding (000's):














      Basic



      61,228



      61,924



      61,310



      63,075


      Fully Diluted



      61,542



      62,127



      61,489



      63,207















      Additional Disclosure:













      Depreciation and amortization(1)


      $

      17,987


      $

      15,453


      $

      63,487


      $

      57,437















      (1) Includes $0.1 million and $0.5 million of amortization of deferred financing costs charged to interest expense for the three months and year ended December 31, 2019, respectively (2018 - $0.1 million and  $1.1 million, respectively).

      IMAX CORPORATION

      CONDENSED CONSOLIDATED BALANCE SHEETS

      In accordance with United States Generally Accepted Accounting Principles

      (In thousands of U.S. dollars)







      December 31,



      2019


      2018

      Assets






      Cash and cash equivalents


      $        109,484



      $       141,590

      Accounts receivable, net of allowance for doubtful accounts of $5,138 (December 31, 2018 — $3,174)


      99,513



      93,309

      Financing receivables, net of allowance for uncollectible amounts


      128,038



      127,432

      Variable consideration receivable from contracts 


      40,040



      35,985

      Inventories 


      42,989



      44,560

      Prepaid expenses


      10,237



      10,294

      Film assets 


      17,921



      16,367

      Property, plant and equipment 


      306,849



      280,658

      Investment in equity securities 


      15,685



      1,022

      Other Assets 


      25,034



      17,997

      Deferred income taxes 


      23,905



      31,264

      Other intangible assets 


      30,347



      34,095

      Goodwill 


      39,027



      39,027

      Total assets 


      $      889,069



      $    873,600







      Liabilities






      Bank indebtedness


      $          18,229



      $         37,753

      Accounts payable


      20,414



      32,057

      Accrued and other liabilities 


      112,779



      97,724

      Deferred revenue


      94,552



      106,709

      Total liabilities 


      245,974



      274,243







      Commitments and contingencies 












      Non-controlling interests 


      5,908



      6,439







      Shareholders' equity












      Capital stock (note 16) common shares — no par value. Authorized — unlimited number
         61,362,872 issued and 61,175,852 outstanding (December 31, 2018 — 61,478,168
         issued and 61,433,589 outstanding)


      423,386



      422,455

      Less: Treasury stock, 187,020 shares at cost (December 31, 2018 — 44,579)


      (4,038)



      (916)

      Other equity


      171,789



      179,595

      Accumulated deficit


      (40,253)



      (85,385)

      Accumulated other comprehensive loss 


      (3,190)



      (3,588)

      Total shareholders' equity attributable to common shareholders


      547,694



      512,161

      Non-controlling interests 


      89,493



      80,757

      Total shareholders' equity


      637,187



      592,918

      Total liabilities and shareholders' equity


      $      889,069



      $    873,600

      IMAX CORPORATION

      CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

      In accordance with United States Generally Accepted Accounting Principles


      (In thousands of U.S. dollars)




      Years Ended December 31,




      2019


      2018









      Cash provided by (used in):








      Operating Activities








      Net income


      $

      58,571


      $

      33,595


      Adjustments to reconcile net income to cash from operations:








      Depreciation and amortization



      63,487



      57,437


      Write-downs, net of recoveries



      6,806



      11,770


      Deferred income taxes



      6,762



      (6,923)


      Stock and other non-cash compensation



      23,570



      23,723


      Unrealized foreign currency exchange loss



      33



      631


      Change in fair value of equity investment



      517



      —


      Loss from equity-accounted investments



      730



      95


      (Gain) loss on non-cash contribution to equity-accounted investees



      (733)



      397


      Investment in film assets



      (23,437)



      (23,200)


      Changes in other non-cash operating assets and liabilities



      (45,929)



      12,447


      Net cash provided by operating activities



      90,377



      109,972










      Investing Activities








      Purchase of property, plant and equipment



      (7,421)



      (13,368)


      Investment in joint revenue sharing equipment



      (40,489)



      (34,810)


      Acquisition of other intangible assets



      (2,931)



      (8,696)


      Investment in equity securities



      (15,153)



      —


      Net cash used in investing activities



      (65,994)



      (56,874)










      Financing Activities








      Increase in bank indebtedness



      35,000



      65,000


      Repayment of bank indebtedness



      (55,000)



      (50,667)


      Treasury stock repurchased for future settlement of restricted share units



      (4,038)



      (916)


      Settlement of restricted share units and options



      (9,795)



      (5,249)


      Repurchase of common shares, IMAX China



      (19,162)



      (6,084)


      Taxes withheld and paid on employee stock awards vested



      (590)



      (1,437)


      Common shares issued - stock options exercised



      2,404



      1,017


      Repurchase of common shares



      (2,659)



      (71,479)


      Issuance of subsidiary shares to non-controlling interests (net of return on capital)



      1,106



      7,796


      Dividends paid to non-controlling interests



      (4,384)



      (6,934)


      Credit facility amendment fees paid



      —



      (1,909)


      Net cash used in financing activities



      (57,118)



      (70,862)










      Effects of exchange rate changes on cash



      630



      629










      Decrease in cash and cash equivalents during period



      (32,106)



      (17,135)


      Cash and cash equivalents, beginning of period



      141,590



      158,725


      Cash and cash equivalents, end of period


      $

      109,484


      $

      141,590


      IMAX CORPORATION
      SELECTED FINANCIAL DATA
      In accordance with United States Generally Accepted Accounting Principles
      (in thousands of U.S. dollars)





      Three Months Ended


      12 Months Ended




      December 31,



      December 31,




      2019



      2018



      2019



      2018


      Revenue













      Network business













      IMAX DMR


      $     26,857



      $     25,207



      $   120,765



      $   110,793


      Joint revenue sharing arrangements – contingent rent


      16,228



      16,452



      75,932



      73,371


      IMAX systems – contingent rent


      (50)



      —



      139



      —




      43,035



      41,659



      196,836



      184,164


      Theater business













      IMAX systems













           Sales and sales-type leases 


      54,098



      37,887



      96,310



      88,432


           Ongoing fees and finance income 


      3,025



      3,242



      11,613



      12,224


      Joint revenue sharing arrangements – fixed fees


      4,489



      5,885



      11,014



      9,706


      Theater system maintenance


      13,336



      12,222



      53,151



      49,684


      Other theater


      2,624



      2,651



      8,390



      8,358




      77,572



      61,887



      180,478



      168,404


      New business


      846



      770



      2,754



      5,769


      Other 













      Film distribution and film post-production


      2,419



      3,806



      12,210



      12,962


      Other


      407



      842



      3,386



      3,102




      2,826



      4,648



      15,596



      16,064


      Total revenues


      $   124,279



      $   108,964



      $   395,664



      $   374,401




























      Gross Margin













      Network business













      IMAX DMR(1)


      $     16,990



      $     15,250



      $     78,592



      $     72,773


      Joint revenue sharing arrangements – contingent rent(1)


      7,498



      9,415



      47,935



      48,856


      IMAX systems – contingent rent


      (50)



      —



      139



      —




      24,438



      24,665



      126,666



      121,629


      Theater business













      IMAX systems(1)













           Sales and sales-type leases 


      28,689



      19,338



      47,118



      47,986


           Ongoing fees and finance income 


      2,977



      3,194



      11,422



      12,033


      Joint revenue sharing arrangements – fixed fees(1)


      1,312



      1,206



      2,613



      1,982


      Theater system maintenance


      5,964



      4,702



      23,010



      21,991


      Other theater


      803



      707



      2,624



      1,806




      39,745



      29,147



      86,787



      85,798


      New business


      665



      (489)



      2,106



      (350)


      Other 













      Film distribution and film post-production(1)


      (1,745)



      1,443



      (1,262)



      1,763


      Other


      (744)



      (124)



      (125)



      (911)




      (2,489)



      1,319



      (1,387)



      852


      Total segment margin


      $     62,359



      $     54,642



      $   214,172



      $   207,929














      (1)

      IMAX DMR segment margins include marketing costs of $4.8 million and $22.5 million for the three months and year ended December 31, 2019, respectively (2018 - $2.8 million and $16.5 million, respectively). Joint revenue sharing arrangements segment margins include advertising, marketing and commission costs of $3.4 million and $4.5 million for the three months and year ended December 31, 2019, respectively (2018 - $1.4 million and $3.6 million, respectively). IMAX system segment margins include marketing and commission costs of $0.5 million and $2.0 million for the three months and year ended December 31, 2019, respectively (2018 - $1.5 million and $2.4 million). Film distribution and post production segment margins include marketing recovery of $0.3 million and expense of $0.4 million for the three months and year ended December 31, 2019, respectively (2018 - $0.2 million and expense of $2.2 million, respectively). 

      IMAX CORPORATION
      OTHER INFORMATION
      (in thousands of U.S. dollars)

      Non-GAAP Financial Measures:

      In this release, the Company presents adjusted net income, adjusted net income per diluted share, adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share, EBITDA, adjusted EBITDA per Credit Facility, free cash flow and return on invested capital as supplemental measures of performance of the Company, which are not recognized under U.S. GAAP. The Company presents adjusted net income and adjusted net income per diluted share because it believes that they are important supplemental measures of its comparable controllable operating performance and it wants to ensure that its investors fully understand the impact of its stock-based compensation (net of any related tax impact) and non-recurring charges on net income. In addition, the Company presents adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share because it believes that they are important supplemental measures of its comparable financial results and could potentially distort the analysis of trends in business performance and it wants to ensure that its investors fully understand the impact of net income attributable to non-controlling interests, its stock-based compensation (net of any related tax impact) and non-recurring charges in determining net income attributable to common shareholders. Management uses these measures to review operating performance on a comparable basis from period to period. However, these non-GAAP measures may not be comparable to similarly titled amounts reported by other companies. Adjusted net income, adjusted net income per diluted share, adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share should be considered in addition to, and not as a substitute for, net income and net income attributable to common shareholders and other measures of financial performance reported in accordance with U.S. GAAP.

      The Company is required to maintain a minimum level of "EBITDA", as such term is defined in the Company's credit agreement (and which is referred to herein as "Adjusted EBITDA per Credit Facility" or "Adjusted EBITDA per Credit Facility excluding Marvel's Inhumans", as the credit agreement includes additional adjustments beyond interest, taxes, depreciation and amortization). EBITDA and Adjusted EBITDA per Credit Facility (each as defined below) should not be construed as substitutes for net income or as better measures of liquidity as determined in accordance with U.S. GAAP. The Company believes that EBITDA and Adjusted EBITDA per Credit Facility excluding Marvel's Inhumans are relevant and useful information widely used by analysts, investors and other interested parties in the Company's industry.




      Three Months Ended



      Three Months Ended



      12 Months Ended



      12 Months Ended





      December 31, 2019



      December 31, 2018



      December 31, 2019(1)



      December 31, 2018(1)

















      Net income

      $

      21,352


      $

      3,771


      $

      58,571


      $

      33,595



      Add (subtract): 


      -












      Provision for income taxes


      4,782



      (22)



      16,768



      9,518



      Interest expense, net of interest income


      381



      (110)



      423



      1,072



      Depreciation and amortization, including film asset amortization


      17,987



      15,453



      63,487



      57,437



      EBITDA

      $

      44,502


      $

      19,092


      $

      139,249


      $

      101,622



      Stock and other non-cash compensation


      6,173



      5,483



      23,570



      23,723



      Change in fair value of equity investment


      (2,026)



      —



      517



      —



      Write-downs, net of recoveries including asset impairments and
         receivable provisions


      3,822



      2,797



      6,806



      5,338



      Exit costs, restructuring charges and associated impairments


      —



      8,384



      850



      9,542



      Legal arbitration award


      —



      4,237



      -



      11,737



      Executive transition costs


      —



      2,994



      -



      2,994



      (Income) loss from equity accounted investments


      (59)



      (15)



      (3)



      492



      Adjusted EBITDA before non-controlling interests

      $

      52,412


      $

      42,972


      $

      170,989


      $

      155,448



      Adjusted EBITDA attributable to non-controlling interests(2)


      (5,457)



      (6,593)



      (21,661)



      (22,220)



      Adjusted EBITDA per Credit Facility

      $

      46,955


      $

      36,379


      $

      149,328


      $

      133,228



      Adjusted revenues attributable to common shareholders(3)

      $

      112,635


      $

      97,573


      $

      358,053


      $

      336,723



      Adjusted EBITDA margin


      41.7

      %


      37.3

      %


      41.7

      %


      39.6

      %

      _____________













      (1)

      Senior Secured Net Leverage Ratio calculated using twelve months ended Adjusted EBITDA per Credit Facility.





      (2)

      The Adjusted EBITDA per Credit Facility calculation specified for purpose of the minimum Adjusted EBITDA covenant excludes the reduction in Adjusted EBITDA from the Company's non-controlling interests. 





      (3)


      Three months ended

      December 31, 2019


      Three months ended

      December 31, 2018


      12 months ended

      December 31, 2019


      12 months ended

      December 31, 2018


      Total revenues




      $

      124,279




      $

      108,964




      $

      395,664




      $

      374,401


      Greater China revenues


      $

      38,481




      $

      35,553




      $

      124,294




      $

      117,520




      Non-controlling interest ownership percentage(4)



      30.26%





      32.04%





      30.26%





      32.06%




      Deduction for non-controlling interest share of revenues





      (11,644)





      (11,391)





      (37,611)





      (37,678)


      Adjusted revenues attributable to common shareholders




      $

      112,635




      $

      97,573




      $

      358,053




      $

      336,723























      (4)

      Weighted average ownership percentage for change in non-controlling interest share





















      IMAX CORPORATION
      Adjusted Net Income and Adjusted Diluted Per Share Calculations
      (In thousands of U.S. dollars)
      (Unaudited)




      Three Months Ended


      Three Months Ended



      December 31, 2019


      December 31, 2018



      Net Income


      Diluted EPS


      Net Income


      Diluted EPS

      Reported net income


      $                    21,352


      $                        0.35


      $                      3,771


      $                        0.06

      Adjustments:




      —





      Stock-based compensation


      5,914


      0.10


      5,046


      0.08

      Exit costs, restructuring charges and associated impairments


      —


      —


      8,384


      0.13

      Legal arbitration award


      —


      —


      4,237


      0.07

      Executive transition costs


      —


      —


      2,994


      0.05

      Change in fair value of equity investment


      (2,026)


      (0.03)


      —


      —

      Impact of enactment of U.S. Tax Act


      —


      —


      —


      —

      Tax impact on items listed above


      (1,095)


      (0.02)


      (4,586)


      (0.07)

      Adjusted net income


      24,145


      0.40


      19,846


      0.32

      Net income attributable to non-controlling interests(1)


      (3,181)


      (0.05)


      (2,077)


      (0.04)

      Stock-based compensation (net of tax of less than
         $0.1 million and less than $0.1 million, respectively)(1)


      (112)


      (0.01)


      (115)


      —

      Exit costs, restructuring charges and associated impairments (net of tax of $nil and $0.4 million, respectively)(1)


      —


      —


      (1,262)


      (0.02)

      Change in fair value of equity investment


      617


      0.01


      —


      —

      Adjusted net income attributable to common shareholders


      $                    21,469


      $                        0.35


      $                    16,392


      $                        0.26










      Weighted average diluted shares outstanding




      61,542




      62,127



















      (1) Reflects amounts attributable to non-controlling interests.






















      12 Months Ended


      12 Months Ended



      December 31, 2019


      December 31, 2018



      Net Income


      Diluted EPS


      Net Income


      Diluted EPS

      Reported net income


      $                    58,571


      $                        0.95


      $                    33,595


      $                        0.53

      Adjustments:









      Stock-based compensation


      22,830


      0.37


      22,211


      0.35

      Exit costs, restructuring charges and associated impairments


      850


      0.01


      9,542


      0.15

      Legal arbitration award


      —


      —


      11,737


      0.19

      Executive transition costs


      —


      —


      2,994


      0.05

      Change in fair value of equity investment


      517


      0.01


      —


      —

      Impact of enactment of U.S Tax Cut and Jobs Act


      —


      —


      —


      —

      Tax impact on items listed above


      (5,614)


      (0.09)


      (9,873)


      (0.16)

      Adjusted net income


      77,154


      1.25


      70,206


      1.11

      Net income attributable to non-controlling interests(1)


      (11,705)


      (0.19)


      (10,751)


      (0.17)

      Stock-based compensation (net of tax of $0.1 million and
         $0.1 million, respectively)(1)


      (480)


      (0.01)


      (394)


      (0.01)

      Exit costs, restructuring charges and associated impairments (net of tax of $nil and $0.4 million, respectively)(1)


      —


      —


      (1,262)


      (0.02)

      Change in fair value of equity investment


      (184)


      —


      —


      —

      Adjusted net income attributable to common shareholders


      $                    64,785


      $                        1.05


      $                    57,799


      $                        0.91










      Weighted average diluted shares outstanding




      61,489




      63,207



















      (1) Reflects amounts attributable to non-controlling interests.



      Return on Invested Capital:

      Return on Invested Capital ("ROIC") is not defined under U.S. generally accepted accounting principles. Therefore, ROIC should not be considered a substitute for other measures prepared in accordance with U.S. GAAP and may not be comparable to similarly titled measures used by other companies. The Company defines ROIC as earnings before interest after taxes (before non-controlling interests) divided by total invested capital (total equity plus total debt less goodwill and other intangible assets). The Company believes ROIC is meaningful to investors as it focuses on shareholder value creation. A reconciliation of ROIC is presented in the table below:



      Twelve Months Ended

      December 31,


      2019


      2018







      Income from operations

      $

      77,278


      $

      45,176

      Provision for income taxes


      (16,768)



      (9,518)

      EBIAT

      $

      60,510


      $

      35,658







      Total shareholders' equity

      $

      637,187


      $

      592,918

      Total bank indebtedness


      18,229



      37,753

      Less: Goodwill


      39,027



      39,027

      Less: Other intangible assets


      30,347



      34,095

      Total Invested Capital

      $

      586,042


      $

      557,549







      Return on Invested Capital (Non-GAAP measure)


      10.33%



      6.40%

      Free Cash Flow:

      Free cash flow is defined as cash provided by operating activities minus cash used in investing activities (from the consolidated statements of cash flows). Cash provided by operating activities consist of net income, plus depreciation and amortization, plus the change in deferred income taxes, plus other non-cash items, plus changes in working capital, less investment in film assets, plus other changes in operating assets and liabilities. Cash used in investing activities includes capital expenditures, acquisitions and other cash used in investing activities. Management views free cash flow, a non-GAAP measure, as a measure of the Company's after-tax cash flow available to reduce debt, add to cash balances, and fund other financing activities. A reconciliation of cash provided by operating activities to free cash flow is presented in the table below:




      Three Months Ended


      12 Months Ended



      December 31, 2019


      December 31, 2019








      Net cash provided by operating activities


      $

      23,119


      $

      90,376

      Net cash used in investing activities



      (12,340)



      (65,994)


      Free cash flow


      $

      10,779


      $

      24,382

      SOURCE IMAX Corporation

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.